← Leaderboards
Graeme John Dougherty
University Of California Los Angeles
$1,669,869
Attributed
$1,669,869
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,669,869 · 2
By mechanism
R01$1,669,869 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Frank Pajonk$12,966,735
- Ichiro Nakano$7,010,147
- Gregory A. Brent$4,669,056
- Erina Vlashi$2,767,478
- Harley I Kornblum$10,891,469
Others in their field
Top investigators on “Cd44 Molecule”
- David Heimbrook · Leidos Biomedical Research, Inc.$26,054,235
- Robert Sackstein · Brigham And Women'S Hospital$12,473,382
- Paul Wesley Noble · Yale University$9,695,694
- Richard J Bucala · Picower Institute For Medical Research$8,731,241
- Paul L Bollyky · University Of Washington$6,803,972
- Harvey Cantor · Brigham And Women'S Hospital$5,890,509
Research focus
Cd44 MoleculeRegulatory GeneRna SplicingRadiation SensitivitySite Directed MutagenesisGene ExpressionProtein IsoformsRadiation Related Neoplasm /CancerRadiation ResistanceRadiation GeneticsCell AdhesionBiological Signal TransductionIonizing RadiationLaboratory MouseLeukemiaNeoplasm /Cancer GeneticsApoptosisPathologic ProcessScid MouseUrinary BladderBladder NeoplasmDna TopoisomerasesEnzyme InhibitorsGene Targeting
Grant awards (9)
Targeting Gene Therapy to Bladder Cancer$264,512
R01 · FY2005 · CA
CD44 AND THE PATHOGENESIS OF HEMOPOIETIC MALIGNANCIES$171,563
R01 · FY2004 · CA
Targeting Gene Therapy to Bladder Cancer$163,089
R01 · FY2004 · CA
Targeting Gene Therapy to Bladder Cancer$111,739
R01 · FY2004 · CA
Targeting Gene Therapy to Bladder Cancer$271,450
R01 · FY2003 · CA
CD44 AND THE PATHOGENESIS OF HEMOPOIETIC MALIGNANCIES$171,563
R01 · FY2003 · CA
CD44 AND THE PATHOGENESIS OF HEMOPOIETIC MALIGNANCIES$171,703
R01 · FY2002 · CA
CD44 AND THE PATHOGENESIS OF HEMOPOIETIC MALIGNANCIES$172,125
R01 · FY2001 · CA
CD44 AND THE PATHOGENESIS OF HEMOPOIETIC MALIGNANCIES$172,125
R01 · FY2000 · CA